The success of copyright’s blockbuster initially sparked a boom for pharma, but recent changes present a complicated picture for shareholders. Generic competitors are eroding profits, and ongoing litigation add https://saulznix995218.blue-blogs.com/49369382/the-blue-pill-and-pharma-a-precarious-play